{"id":1063313,"date":"2010-04-27T08:18:09","date_gmt":"2010-04-27T08:18:09","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/sessions-on-csc-therapeutics-at-aacr10\/"},"modified":"2024-08-17T20:28:38","modified_gmt":"2024-08-18T00:28:38","slug":"sessions-on-csc-therapeutics-at-aacr10","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/sessions-on-csc-therapeutics-at-aacr10.php","title":{"rendered":"Sessions on CSC Therapeutics at AACR10"},"content":{"rendered":"<p>There were two poster sessions on Cancer Stem Cell Therapeutics at the <a title=\"101st Annual Meeting\" href=\"http:\/\/www.abstractsonline.com\/Plan\/start.aspx\" target=\"_blank\" rel=\"noopener\">101st Annual Meeting<\/a> of the  American Association for Cancer Research (<a title=\"AACR\" href=\"http:\/\/www.aacr.org\/\" target=\"_blank\" rel=\"noopener\">AACR<\/a>). The sessions, <a title=\"Cancer Stem Cell Therapeutics 1\" href=\"http:\/\/bit.ly\/blZTp4\" target=\"_blank\" rel=\"noopener\">Cancer Stem Cell Therapeutics 1<\/a> and <a title=\"Cancer Stem Cell Therapeutics 2\" href=\"http:\/\/bit.ly\/dlTlge\" target=\"_blank\" rel=\"noopener\">Cancer Stem Cell Therapeutics 2<\/a>, took place on the morning and afternoon of April 20, 2010 [<a title=\"FriendFeed entry\" href=\"http:\/\/ff.im\/jkY35\" target=\"_blank\" rel=\"noopener\">FriendFeed entry<\/a>].<\/p><p>Two posters presented in the 2nd session have been highlighted in a news release. See: <a title=\"Alchemia&rsquo;s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer\" href=\"http:\/\/bit.ly\/cS5SD0\" target=\"_blank\" rel=\"noopener\">Alchemia&rsquo;s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer<\/a>, <em>Business Wire<\/em>, April 20, 2010 [<a title=\"FriendFeed entry\" href=\"http:\/\/ff.im\/jemiV\" target=\"_blank\" rel=\"noopener\">FriendFeed entry<\/a>]. One of these is Poster #4293: <a title=\"Evaluation of activated CD44 as a biological target in the eradication of breast cancer stem cells\" href=\"http:\/\/www.alchemia.com.au\/IRM\/Company\/ShowPage.aspx?CPID=1529&amp;EID=71415979&amp;PageName=AACR%202010%20Breast%20Cancer%20Stem%20Cell%20Presentation\" target=\"_blank\" rel=\"noopener\"><em>Evaluation of activated CD44 as a biological target in the eradication of breast cancer stem cells<\/em><\/a>, by Vera J Evtimov and <a title=\"Tracey J Brown\" href=\"http:\/\/www.med.monash.edu.au\/biochem\/staff\/brown-t.html\" target=\"_blank\" rel=\"noopener\">Tracey J Brown<\/a> [<a title=\"Presentation Abstract\" href=\"http:\/\/www.abstractsonline.com\/Plan\/ViewAbstract.aspx?mID=2521&amp;sKey=c8503a5d-cbe1-43fd-9652-46df1acdf9dd&amp;cKey=627df9e1-f4fd-49a8-a3a4-f27f43c6bb5c&amp;mKey=%7B0591FA3B-AFEF-49D2-8E65-55F41EE8117E%7D\" target=\"_blank\" rel=\"noopener\">Presentation Abstract<\/a>]. The other is Poster #4278: <em>HA-Irinotecan targeting of activated CD44 is an effective therapy for the eradication of putative colon cancer  stem cells <\/em>[<a title=\"Presentation Abstract\" href=\"http:\/\/www.abstractsonline.com\/Plan\/ViewAbstract.aspx?mID=2521&amp;sKey=c8503a5d-cbe1-43fd-9652-46df1acdf9dd&amp;cKey=6dedb91d-7f06-44a1-9cd6-d69c7de381b4&amp;mKey=%7B0591FA3B-AFEF-49D2-8E65-55F41EE8117E%7D\" target=\"_blank\" rel=\"noopener\">Presentation Abstract<\/a>].<\/p><div><img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/b69bb_35997458635844014-6873927435224291858?l=cancerstemcellnews.blogspot.com\" alt=\"\" style=\"padding-left:10px; padding-right: 10px;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>There were two poster sessions on Cancer Stem Cell Therapeutics at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The sessions, Cancer Stem Cell Therapeutics 1 and Cancer Stem Cell Therapeutics 2, took place on the &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/sessions-on-csc-therapeutics-at-aacr10.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063313","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063313"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063313"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063313\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}